New Molecular Technologies for Minimal Residual Disease Evaluation in B-Cell Lymphoid Malignancies

The clearance of malignant clonal cells significantly correlates with clinical outcomes in many hematologic malignancies. Accurate and high throughput tools for minimal residual disease (MRD) detection are needed to overcome some drawbacks of standard molecular techniques; such novel tools have allo...

Descripción completa

Detalles Bibliográficos
Autores principales: Dogliotti, Irene, Drandi, Daniela, Genuardi, Elisa, Ferrero, Simone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162632/
https://www.ncbi.nlm.nih.gov/pubmed/30231510
http://dx.doi.org/10.3390/jcm7090288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162632/
https://www.ncbi.nlm.nih.gov/pubmed/30231510
http://dx.doi.org/10.3390/jcm7090288

Ejemplares similares